TGFB2 and myopia: These findings reinforce the concept that subconjunctivally administered TGF-β2, while not directly entering the retina, can stimulate intraocular signaling cascades via the choroid–RPE axis, leading to increased local TGF-β expression and downstream pathological remodeling relevant to myopia progression.